Outcomes of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory HIV-associated lymphoma

Ramaswami R.; Pria A. Dalla; Parker K.; McCann S.; Kanfer E. J.; Nelson M.; Bower M.

首页> 外文期刊>Bone marrow transplantation >Outcomes of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory HIV-associated lymphoma

【24h】

Outcomes of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory HIV-associated lymphoma

机译：复发/难治性HIV相关淋巴瘤患者自体干细胞移植（ASCT）的结果

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Bone marrow transplantation》 |2016年第12期|共3页
作者
Ramaswami R.; Pria A. Dalla; Parker K.; McCann S.; Kanfer E. J.; Nelson M.; Bower M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类治疗学;
关键词

相似文献

外文文献
中文文献
专利

1. Outcomes of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory HIV-associated lymphoma [J] . Ramaswami R., Pria A. Dalla, Parker K., Bone marrow transplantation . 2016,第12期

机译：复发/难治性HIV相关淋巴瘤患者自体干细胞移植（ASCT）的结果
2. Yttrium-90 ibritumomab tiuxetan (Zevalin) followed by BEAM (Z-BEAM) conditioning regimen and autologous stem cell transplantation (ASCT) in relapsed or refractory high-risk B-cell non-Hodgkin lymphoma (NHL): a single institution Italian experience [J] . Ciochetto Chiara, Botto Barbara, Passera Roberto, Annals of hematology . 2018,第9期

机译：Yttrium-90 ibritumomab Tiuxetan（Zevalin）随后是梁（Z-梁）调节方案和自体干细胞移植（ASCT）复发或难治性高风险B细胞非霍奇金淋巴瘤（NHL）：一种机构意大利经验
3. Patients with Relapsed/Refractory Large Cell Lymphoma Who Were Also Refractory to Salvage Chemotherapy: Outcome with Salvage Radiation Therapy Followed by Autologous Stem Cell Transplant [J] . Yang J. C., Chau K., Scordo M., International Journal of Radiation Oncology, Biology, Physics . 2018,第3Suppla期

机译：复发/难以解决的大细胞淋巴瘤患者，令人难以忍受的拯救化疗：拯救辐射治疗的结果，然后是自体干细胞移植
4. Clinical Outcome of Breast and Ovarian Cancer Patients Treated after High-Dose Chemotherapy and Autologous Stem Cell Rescue with Theratope (STn-KLH) Cancer Vaccine: Theratope (STn-KLH) Cancer Vaccine following Autologous Transplant [C] . Leona A. Holmberg, Katherine A. Guthrie, Brenda M. Sandmaier Chemical glycobiology . -1

机译：大剂量化学疗法和自体干细胞拯救治疗的Theratope（STn-KLH）癌症疫苗治疗的乳腺癌和卵巢癌患者的临床结果：自体移植后的Theratope（STn-KLH）癌症疫苗
5. Safety and Efficacy of the Immunomodulatory Drug (IMiD) Lenalidomide in Patients with Lymphoma: Development of RU051417I - Phase I/II Open-Label Study of R-ICE (Rituximab-Ifosfamide-Carboplatin-Etoposide) with Lenalidomide [R2-ICE] in Patients with First-Relapse/Primary Refractory Diffuse Large B-Cell Lymphoma (DLBCL). [D] . Kasi, Pashtoon Murtaza. 2018

机译：免疫调节药物来那度胺在淋巴瘤患者中的安全性和有效性：RU051417I-R-ICE（利妥昔单抗-异环磷酰胺-卡铂-依托泊苷）与来那度胺[R2-ICE]的I / II期开放标签研究的进展初次复发/原发性难治性弥漫性大B细胞淋巴瘤（DLBCL）。
6. R-ESHAP as salvage therapy for patients with relapsed or refractory diffuse large B-cell lymphoma: influence of prior autologous stem-cell transplantation on outcome [O] . Alejandro Martín, María-Dolores Caballero 2009

机译：R-ESHAP作为复发性或难治性弥漫性大B细胞淋巴瘤患者的挽救疗法：先前自体干细胞移植对预后的影响
7. Gemcitabine, Busulfan and Melphalan (Gem/Bu/Mel) Is a New High-Dose Chemotherapy (HDC) Regimen with High Activity in Refractory or Poor-Risk Relapsed Non-Hodgkin'S Lymphoma (NHL) Patients Receiving an Autologous Stem-Cell Transplant (ASCT) [O] . Nieto Y., Jones R.B., Popat U., 2012

机译：吉西他滨，白消安和美法仑（Gem / Bu / Mel）是一种新型的高剂量化学疗法（HDC）方案，在接受自体干细胞移植（ASCT）的难治性或低危复发非霍奇金淋巴瘤（NHL）患者中具有高活性）

Outcomes of autologous stem cell transplantation (ASCT) in patients with relapsed/refractory HIV-associated lymphoma

著录项

相似文献

相关主题

期刊订阅